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Abstract
Background: People with dementia progressively lose abilities and are prone to falling. Exercise- and activity-based
interventions hold the prospect of increasing abilities, reducing falls, and slowing decline in cognition. Current falls
prevention approaches are poorly suited to people with dementia, however, and are of uncertain effectiveness. We
used multiple sources, and a co-production approach, to develop a new intervention, which we will evaluate in a
feasibility randomised controlled trial (RCT), with embedded adherence, process and economic analyses.
Methods: We will recruit people with mild cognitive impairment or mild dementia from memory assessment clinics,
and a family member or carer. We will randomise participants between a therapy programme with high intensity
supervision over 12 months, a therapy programme with moderate intensity supervision over 3 months, and brief falls
assessment and advice as a control intervention. The therapy programmes will be delivered at home by mental health
specialist therapists and therapy assistants. We will measure activities of daily living, falls and a battery of intermediate
and distal health status outcomes, including activity, balance, cognition, mood and quality of life. The main aim is to
test recruitment and retention, intervention delivery, data collection and other trial processes in advance of a planned
definitive RCT. We will also study motivation and adherence, and conduct a process evaluation to help understand
why results occurred using mixed methods, including a qualitative interview study and scales measuring psychological,
motivation and communication variables. We will undertake an economic study, including modelling of future impact
and cost to end-of-life, and a social return on investment analysis.
Discussion: In this study, we aim to better understand the practicalities of both intervention and research delivery,
and to generate substantial new knowledge on motivation, adherence and the approach to economic analysis. This
will enable us to refine a novel intervention to promote activity and safety after a diagnosis of dementia, which will
be evaluated in a definitive randomised controlled trial.
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Background
Dementia is a syndrome of progressive and usually irre-
versible loss of memory and other cognitive functions
including agnosia, apraxia, language and executive func-
tion, caused by a variety of brain diseases, and severe
enough to interfere with daily function. Mild cognitive
impairment (MCI) is defined by measureable memory
loss or other cognitive decline in the absence of interfer-
ence with daily function, but which progresses to de-
mentia in about half of cases. Dementia affects 1% of
those at age 65, 20% at age 80 and 30% or more at age
90. Prevalence in the UK is about 850,000, and expected
to double by 2030 [1].
There is no cure for dementia, but acetylcholinesterase
inhibitor drugs and cognitive stimulation therapy can
improve cognition by a modest amount [2, 3]. There are
few other interventions to maintain or improve health
status. Two potential mechanisms for avoidable deterior-
ation in cognition and function are crises associated with
physical health problems (such as falls and their conse-
quences), and progressive restriction of activity by the
person with dementia or those who support and care for
them, often with the goal of maintaining safety.
A fall is defined as unintentionally coming to rest on
the floor or at a lower level, through whatever cause [4].
People with dementia and MCI are at high risk of falling
with at least a twofold increased risk compared with
cognitively normal older people [5–7]. This equates to
an annual fall incidence of 60–80% [8–11]. Conse-
quences of falls include fractures, other injuries, hospital
attendance, the ‘fear of falling syndrome’, immobility and
loss of independence. People with dementia also have a
higher risk of fractures, hip fractures in particular, and
poorer outcomes after fracture, compared with people
who are cognitively intact [6, 12]. Up to a third of emer-
gency hospital admissions occur in an older person with
dementia, and over half of these are associated with a
fall [13]. Each year, in the UK, there are 75,000 hip frac-
tures, set to rise by half again in the next 10 years, and
200,000 other fragility fractures. The combined cost of
these is over £2 billion per year, and use 1.6 million hos-
pital bed days. Half of hip fractures occur in someone
with dementia [14].
There has been extensive research into falls prevention
in older people. Risk factors are muscle weakness,
neurological disease, medications, poor vision and envir-
onmental factors. Multi-factorial interventions reduce
risk [15, 16] but these interventions have not been
shown to reduce falls in people with dementia or MCI
[8, 17–19]. A systematic review of interventions con-
cluded that they were poorly adapted to the needs of
people with dementia [20]. Falls guidelines recommend
that cognitive function is assessed, but do not say how
to respond [21]. People with dementia have more ‘con-
ventional’ falls risk factors than people of similar age
without dementia [8]. They also have dementia-specific
risk factors including: type and severity of dementia, spe-
cific cognitive and gait deficits, behavioural disturbances,
and psychotropic drug use [11, 22, 23]. Studies highlight
the importance of attention, and dual-task cost (in-
creased risk when concentrating on two things at once)
[24], manifestations of impaired executive function (abil-
ity to form, maintain, and shift mental set [25]). Abnor-
malities in executive function and gait are associated
with falls [26, 27]. Dual-task and gait abnormalities are
found early in dementia [11, 28–31] and MCI [32] be-
yond what would be considered ‘normal ageing’.
Potentially reversible risk factors provide opportunities
to intervene before inevitable deterioration occurs. Sys-
tematic reviews have considered the impact of strength
and balance training in older people, with and without
dementia [19, 33–37]. Moderate-intensity exercise, 2–3
times a week, improves strength, gait speed, and ability
in activity of daily living [38–42]. There may be add-
itional benefit in slowing cognitive decline [38, 41, 43–
47] although the size of this effect appears small. Train-
ing can improve executive function, dual-task perform-
ance and gait parameters [48–52]. Functionally
orientated therapy can improve ability to perform activ-
ities of daily living [44, 53, 54]. There is insufficient evi-
dence to confirm reduction in falls, improved mood or
behaviour for people with dementia, or reduced carer
strain [19, 20, 38, 40, 45, 55]. Customary levels of phys-
ical activity are low among older people [56].
The FINALEX trial of 12 months of twice-weekly, su-
pervised exercise at home for people with established
dementia and their co-resident spouse, reduced deterior-
ation in activities of daily living and halved the rate of
falling, from 3.1 to 1.4 falls per person-year [57].
Hospital admissions and overall costs were reduced. This
demonstrates that intensive exercise is achievable,
sustainable with the right support, and cost-effective.
The challenge is how to achieve sufficient participation,
adherence and persistence in the NHS and UK cultural
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environment, and to be inclusive, for example, of the
50% of people with early dementia who live alone.
A new intervention must lead to changes in individ-
uals that are physiologically and neuro-psychologically
credible, but must also take account of aspects of behav-
iour change [58–61]. The utility of current approaches
to behaviour change (e.g. behaviour change wheel [58])
in the context of dementia is unknown, but provides a
framework for further investigation. Barriers to sustain-
ing a moderate to vigorous exercise programme include
not perceiving oneself as being at risk from falls; per-
ceived lack of relevance of exercise or other interven-
tions; and focus on priorities such as maintaining
independence, or family, social or domestic concerns
[62–64]. Barriers to long-term adherence include forget-
fulness, medical co-morbidities, planning problems and
practical support. Motivational strategies might include
supervision, tailoring, remote feedback, prompts, mem-
ory aids, goal setting, and rote-learning habit formation
[65–72]. This problem has been studied in other condi-
tions; for example, adherence to exercise in chronic
musculo-skeletal pain [71], but overall evidence is
sparse. It is not clear which, if any, strategies are accept-
able and effective for people with dementia.
Methods
Aim
This research aims to develop and test a novel interven-
tion to maintain activity and reduce falls in older adults
with MCI and mild dementia.
The feasibility study aims to answer practicability and
feasibility questions about recruitment and retention of
participants, study procedures, delivery, intensity and
burden of intervention, adherence, data collection and
completion of outcomes measures, and implementation
of a rehabilitation staff training programme to ensure
that a planned large-scale trial is successful.
We will study how to maximise participant adherence
with the programme, developing practical strategies to
optimise adherence, and ascertaining in retrospect what
did and did not work for particular individuals, both
during the therapy programme and in the long term.
We will undertake a process evaluation, studying fidel-
ity, understanding mechanisms and context, including
barriers and facilitators to participation.
We will collect resource-use data to enable prelimin-
ary economic modelling.
Study design
A two-centre, pragmatic, parallel group, feasibility RCT
will be conducted (Figs. 1 and 2). After informed con-
sent, participants will be randomised to one of two inter-
vention arms (high- or moderate-intensity supervision)
or a control group who will receive standard falls assess-
ment and advice. Where possible, each participant will
nominate a family member, friend or carer to be both an
informant and a participant in their own right. A process
evaluation [73], study of motivation and adherence, and
a preliminary economic analysis will be undertaken,
using mixed qualitative and quantitative methods.
Setting
Recruitment will be from locality-based, secondary-care
memory clinics, and therapy delivered in the partici-
pant’s home.
Participants (inclusion, exclusion, withdrawal)
Eligible patient participants will be aged over 65 years
and will have a diagnosis of mild dementia or MCI (of
any subtype), attendance at a memory assessment ser-
vice, or on the ‘Join Dementia Research’ register (a na-
tional initiative to encourage participation in dementia
research [74]) with a cognitive score ranging 15–25 on
the Montreal Cognitive Assessment (MoCA) [75], 18–26
on the standardised Mini-Mental State Examination
Fig. 1 Overview of assessment and intervention. PT physiotherapist, OT
occupational therapist, GP general practitioner/family doctor, wk. week
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(sMMSE) [76], or 60–90 on the Addenbrooke’s Cogni-
tive Examination (ACE-III) [77].
Patient participants must be able to walk without hu-
man help, able to communicate in English, and to be
able to see, hear and have dexterity sufficient to perform
neuropsychological tests. Patient participants must have
capacity to give consent to participate, and provide writ-
ten informed consent. Capacity will be assessed and con-
sent taken by a research assistant.
Exclusion criteria for patient participants include co-
morbidity preventing participation (e.g. severe breath-
lessness, pain, psychosis, Parkinson’s disease, or other
severe neurological disease), life expectancy of less than
1 year, or being unlikely to undertake the intervention
regularly (e.g. planned elective surgery, planning to move
away, or commitments elsewhere).
Individual participants will discontinue participation if:
they withdraw consent or no longer wish to take part; the
therapist overseeing their care decides the participant is
no longer able to take part (for example due to inter-
current illness or injury, progression of their disease or in-
ability to adhere despite adjustment and tailoring of the
programme); otherwise at the discretion of the investiga-
tor (e.g. risk to safety of staff ). Participants may opt not to
take part in individual therapy sessions or a series of ses-
sions (e.g. because of holidays or intercurrent illness)
without withdrawing from the study. We will collect out-
come data from those who withdraw if they are willing.
No formal sample size was calculated for the feasibility
study; however, a sample size of 60 was considered suffi-
cient to answer feasibility questions and enable the con-
duct of the adherence and process of evaluations.
Carer participants will be partners, family members or
others in a caring relationship, who are in contact with
the patient participants most weeks, are willing to take
part and can communicate in English.
For the ‘optimising engagement and adherence’ and
process evaluations, we will conduct interviews and
focus groups. We will undertake three small focus
groups with patients with mild dementia, and their fam-
ily carers, each comprising three to five participants to
investigate promotion of adherence. In the process
evaluation, we will conduct semi-structured interviews
with about ten participants in each active-treatment arm
(moderate- and high-intensity supervision). Carers will
be interviewed separately or together with the partici-
pant, depending on their preference. We will select for
interview participants with low- and high-adherence,
identified through their exercise diaries, self-report or
therapist-report. We will also seek to interview a
sample of participants who discontinue the interven-
tion (up to 10, and their carers). We will undertake
Fig. 2 Schedule of enrolment, interventions and assessments
Harwood et al. Pilot and Feasibility Studies  (2018) 4:49 Page 4 of 12
two to three staff focus group discussions, each of six
to eight members.
Randomisation
Participants will be individually randomised on a 1:1:1
ratio, stratified by site, co-resident carer and history of
falls, using an independent, secure, web-based, random-
isation procedure that can be accessed 24 h a day and
held at the NWORTH clinical trials unit, Bangor Univer-
sity [78]. The randomisation system will be maintained
by a statistician independent of the analysis and research
teams to ensure blinding of allocation and analysis.
Blinding
A research assistant will perform the randomisation
and communicate the allocation to the intervention
service provider. Research assistants collecting base-
line and follow-up data by questionnaires or tele-
phone will be blind to treatment allocation, and will
request participants not to reveal their treatment
group. Due to the nature of the intervention, blinding
of the intervention is impossible for participants and
therapists administering it.
Baseline data
Pairs of research assistants will administer data collec-
tion questionnaires by interviewing participant and carer
separately at the participant’s home.
Baseline data will comprise:
 Demographic and contact details for patient and
carer participants
 Medical and falls history, including previous
fractures, recent hospitalisation and medication
 Falls risk factors, including vision and lying and
standing blood pressure
 Gross cognition (sMMSE [76], Clinical Dementia
Rating [79])
 CANTAB neuropsychological assessment: Paired
Associated Learning (PAL), Attention Switching
Task (AST), Spatial Working Memory (SWM)
(Cambridge Cognition, Cambridge, UK)
 Verbal fluency (from MOCA test [75])
 Scaled outcome variables measuring activities of daily
living (ADL) (Disability Assessment for Dementia
scale, DAD [80], Nottingham Extended ADL Scale
[81]), activity (Incidental and Planned Activity
Questionnaire, IPAQ) [82], quality of life (EQ-5D [83],
DEMQoL (participant and proxy) [84]), fear of falling
(short falls efficacy scale, FES-I [85]), Hospital Anxiety
and Depression Scale (HADS) [86], muscle strength
(Lafayette dynamometer, Lafayette, IN), Berg Balance
Scale [87], Timed Up and Go test [88], SHARE frailty
instrument [89].
 Carer strain (caregiver strain index) [90].
 Participant and carer service use (Client Service
Receipt Inventory, CSRI) [91].
Intervention
The intervention was developed by a multi-disciplinary
team of physiotherapists, occupational therapists, doc-
tors, nurses, psychologists, and patient and public repre-
sentatives, using the principles of co-production. This
was informed by findings from three literature reviews
[92–94], clinician, health psychology and neuropsycho-
logical expertise ascertained by interview and during
workshops, focus group discussions held with patients,
carers, and clinicians, and the views of patients and their
carers from a prior interview study [62]. Ten patients
were treated in a 6-week ‘proof of concept’ study as part
of the intervention development, in which intermediate
outcomes were measured and field notes were thematic-
ally analysed. A comprehensive manual was written, and
a training programme devised for physiotherapist,
occupational therapist and rehabilitation support worker
staff. A therapy workbook was designed to be left in
participants’ homes.
The intervention is grounded in established fall preven-
tion expertise, the Assessment of Motor Process Skills
activity assessment [95] and theories of motivation (e.g.
self-determination theory). It includes a professional assess-
ment of ability, risk and goals. We will use capability-based
‘tailoring’: using assessed neuropsychological impairments,
usual level of physical activity, co-morbidities, aligning ac-
tivities to interests, and assessing priorities through goal-
identification and goal-setting. A programme of activities
and exercises will be agreed with the patient and carer.
Therapy includes functional activity, training and advice,
environmental assessment, strength and balance exercises,
and dual-task training. The programme will be set out in
the participant’s workbook in a format easily accessible to
them and their carer. Participants will be encouraged
to perform exercises three times per week, and part-
ners, family members or carers will be asked to
prompt and support, by telephone if necessary, or to
participate as well. The programme will be progres-
sive, intensive and supported by varying intensity of
supervision from the research therapists (Fig. 1).
The control arm will be the offer of a standard falls as-
sessment and advice completed by a therapist, with up
to two follow-up visits if thought clinically necessary.
The moderate-intensity supervision arm participants
(3-month programme) will receive a total of 11 treat-
ment sessions: 6 from an occupational therapist (OT) and
5 from a physiotherapist over 12 weeks. Participants will
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be expected to exercise and complete activities independ-
ently between supervised sessions, and taught to continue
after the supervision period has stopped. The moderate-
intensity intervention was modelled on the intervention in
an ongoing Australian trial [96, 97].
The higher-intensity supervision arm (12-month
programme) will comprise 11 treatment sessions from
registered therapists: 6 from an occupational therapist,
5 from a physiotherapist plus supervised support from
a rehabilitation support worker (RSW) twice a week
for 3 months, once a week for 3 months, once a fort-
night for 3 months, and once a month for 3 months.
In total they will get 51 treatment sessions, and will
be asked to continue with the intervention
programme independently as supervision tapers. At
initial, review and progression points, the RSW will
visit jointly with the therapists.
The feasibility and practicability study, and associated
process evaluation, forms part of the development
process for the intervention, which will be subject to fur-
ther refinement based on the findings. For this reason,
we will not publish the manual until the intervention is
finalised (anticipated September 2018).
Follow-up
Researchers will visit participants at home at 12 months
(± 2 weeks) to complete health status assessments by
interview with the participant and informant. Participants
will keep a daily diary for 12 months, detailing activities
and exercises undertaken and recording falls. This will be
supported and prompted by monthly telephone calls [98].
Measures will be taken to ensure that falls ascertainment
is not biased across the intervention arms (e.g. therapists
or RSWs will be asked not to prompt recall of falls).
Health and social care use will be ascertained during the
telephone calls, using electronic healthcare records and
the Client Service Receipt Inventory (CSRI) at follow-up
interview. Persistence with the therapy programme, health
and social care use, and hospitalisation will be ascertained
by short questionnaire at 18 and 24 months.
Outcome measures
Trial feasibility outcomes
The feasibility outcomes are recruitment, retention, ad-
herence and acceptability of the intervention, and com-
pletion of baseline and outcome data. A recruitment log
will be maintained, and recruitment and withdrawal
rates recorded.
Health status outcome measures
 Disability Assessment for Dementia (DAD) ADL
scale [80]
 Nottingham Extended ADL scale [81]
 IPAQ activity questionnaire [82]
 CANTAB neuropsychological assessment: Paired
Associated Learning (PAL), Attention Switching
Task (AST), Spatial Working Memory (SWM)
 Verbal fluency
 DEMQoL and EQ-5D quality of life questionnaires
[83, 84]
 Short falls efficacy scale (fear of falling, FES-I) [85]
 Hospital Anxiety and Dementia Scale (HADS) [86]
 Berg balance Scale [87]
 Single- and dual-task Timed up and Go (TUG) test [88]
 SHARE frailty instrument [89]
 Muscle strength (Lafayette dynamometer)
 Resting and post-exercise pulse rate.
 Carer strain [90]
Falls and activity
Study-related and other activity will be quantified by
time using the daily diary. Falls and injurious falls will
be counted. Participants will be asked to wear pe-
dometers in weeks 1, 26 and 50 as an objective meas-
ure of activity.
Process evaluation, motivation and adherence study
We will record the number of therapy sessions delivered.
We will estimate amount of exercises and prescribed
activities done independently using the daily diary.
Data on habit formation will be collected at alternate
months by telephone, using a standardised scale, the
Self-Reported Habit Index [99].
At months 1, 3 and 6 data on participant’s and staff
perceptions of motivational communication will be col-
lected by telephone, using the Healthcare Climate Ques-
tionnaire, adapted for exercise settings [100, 101].
Central to self-determination theory is the concept of
basic psychological needs [102]. These needs (for com-
petence, autonomy, and relatedness) must be satisfied
for people to develop and function in healthy or optimal
ways [103]. We will record psychological variables
hypothesised to be related to adherence at baseline and
follow-up:
 Behavioural Regulation in Exercise Questionnaire
(BREQ-2) [104]
 Basic Psychological Need Satisfaction and
Frustration Scale [105] (participants and staff )
 Clinician’s work motivation (Work Extrinsic and
Intrinsic Motivation Scale) [106].
Qualitative interviews will take place at home. Thera-
pists and their assistants delivering the intervention will
take part in focus group discussions, with an experienced
facilitator, held at a convenient location. Interviews and
focus group discussions will be audio-recorded. We will
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ask about: the experience of undertaking the programme;
perceived benefits or value; difficulties, barriers, and facili-
tators; mechanisms of behaviour change and habituation
to the exercise regime; the impact of supervision intensity
and other factors on acceptability and adherence; and
whether level of supervision can be matched to individual
participant characteristics; reasons for high- or low-levels
of adherence, or discontinuation of the programme; the
acceptability of carer support; and the extent of burden
this might impose.
Thirty purposively-selected therapy sessions will be
video-recorded, to include a range of clinicians and
stages of the intervention.
The experience of delivering the intervention will be
explored in focus groups with staff. We will discuss: ad-
equacy of the training; the experience of delivering the
intervention; perceptions of patient and carer responses;
perceived effectiveness; barriers to implementation and
how these may be overcome.
Adverse events
This is a non-drug intervention trial, using interventions
that are within current recommended exercise guidelines,
and might be offered as part of a routine clinical service.
As such, the risk of severe or unexpected adverse events is
low. Dementia is progressive and both cognition and func-
tion may deteriorate in the course of the study. Comorbid-
ity and inter-current illness will be very common. A
balance must be drawn between ensuring the safety of
participants, and failing to identify specific risks amidst
numerous reports of un-related incidents.
Falls, injuries, hospital admissions and deaths will be
ascertained prospectively as part of the trial outcomes.
They will be recorded through diaries, supported by tele-
phone calls from (blinded) researchers where necessary,
and by examining electronic health records.
We will define an adverse event as an incident, injury or
symptom related to therapy sessions, or exercise under-
taken independently. The most likely adverse events are fa-
tigue, minor musculo-skeletal symptoms or injuries such as
muscle stiffness, or sprains, or increased falls though in-
creased activity. Some conditions such as arthritis or angina
may be exacerbated by exercise. Adverse events will be
monitored by therapists and RSWs, and reported where
they occur. However, this will give a biased impression of
prevalence, as the different treatment arms have substan-
tially different amounts of contact with professional staff.
Medical judgement will be exercised in deciding whether
an adverse event is serious, expected or causally-related.
Data management
Data management will be according to the Standard
Operating Procedures of NWORTH CTU. Quantitative
data will be entered into a MACRO database, written
and maintained by NWORTH CTU, by research assis-
tants. This incorporates range checks at the point of
data entry. Data will be further checked by the study
statistician, and a sample verified against source docu-
ments. Qualitative (audio-and video-recorded) data will
be transcribed and anonymised, and managed using
NVivo 11 software (QSR International, Daresbury, UK).
The research grant co-applicants will have access to the
final dataset. Paper records will be securely archived
according to University of Nottingham standard operat-
ing procedures.
Statistics and data analysis
Feasibility analysis
The main analysis will be of feasibility outcomes. We
will calculate:
 Recruitment rate (randomisations per month)
 Retention rate (proportion completing therapy
programme and study follow-up)
 Therapy adherence rate (proportion of professionally-
supervised visits undertaken, and time spent doing
self-directed therapeutic exercise or activity)
 Missing data (proportion fully completed, for each
scale, at each time point).
Participant throughput and flow will be summarised
for each trial arm using a CONSORT diagram. Reasons
for non-eligibility, non-treatment, withdrawals and non-
completion of questionnaires will be reported.
Efficacy analysis
Descriptive statistics (e.g. means, medians, proportions,
standard deviations and ranges) of baseline demo-
graphic, health status and service use data will be calcu-
lated for each trial treatment arm.
We will compare changes in health status outcomes
between the three trial arms.
The Disability Assessment for Dementia and Notting-
ham Extended ADL scale outcomes will be compared
using an analysis of covariance to adjust for the baseline
score and stratifying variables. The nature of the distri-
bution of the falls data will also be examined to deter-
mine how best to analyse the falls data in the main trial.
Statistical analysis will be performed on an intention-to-
treat basis. There will be no imputing of missing data.
Assumptions in determining the sample size of the main
trial will be checked.
Qualitative analysis
Data will be coded and a thematic analysis undertaken
using the principles of constant comparison [107, 108].
A separate coding frame will be developed for each data-
set after which themes from each will be systematically
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compared. Each coding frame will be developed through
the independent coding of about five transcripts and as-
sociated field notes by at least three researchers. It-
erative comparison and discussion will continue until
the coding frame has stabilised. Subsequent tran-
scripts will be coded by a research fellow, with 10%
double-coded to establish consistency and increase
comprehensiveness. Coding will incorporate a priori
topics of relevance to the study; for example: ‘under-
standing of dementia’, ‘relevance of exercise’, ‘motiv-
ation’, ‘burden’, ‘comorbidity’ and others identified
inductively from the data.
Coding proceeds through three stages. Open coding
(indexing of sections of text/video themes to ‘nodes’);
detailed scrutiny of the content of each node (‘coding
on’) when coding is refined through reorganisation
and reallocation into subnodes, and regrouping of
nodes and subnodes into a hierarchical structure
(‘tree’); relating sub-nodes to overarching core themes.
Each data set will be subject to both separate and in-
tegrated analysis. Findings will be synthesised through
charting and matrix displays.
Process evaluation
We will follow MRC guidance (2014) [73] on process
evaluation, which describes three components using a
mixed-methods approach: implementation or delivery;
mechanisms of impact; contextual factors.
Implementation (delivery of intervention), includes
fidelity (quality of delivery) and dose (quantity of deliv-
ery). Records of therapy sessions undertaken and self-
directed activity will be examined, and video-recorded
therapy sessions will be assessed qualitatively for fidelity.
Mechanisms of impact and contextual factors include
engagement and adherence. These will be investigated
through the qualitative studies.
We will also do a qualitative analysis of 10 purposively-
selected video-recorded intervention sessions, which will
be transcribed and analysed. Sessions will be selected to
include a range of professionals, patient participants and
stages of intervention delivery. We will use these to derive
insight into: intervention delivery in real world settings; its
consistency; interactions between patient, carer and pro-
fessional participants; patient and carer responses and en-
gagement with the intervention; the circumstances and
contextual factors influencing engagement; models of best
practice in delivering the intervention.
Optimising uptake and adherence
Using the Capability, Opportunity, Motivation – Behav-
iour (COM-B) framework [58], we will seek evidence on
what support participants would like, or will need, to
achieve short- and long-term adherence. We will review
methods to support uptake and adherence in exercise
interventions reported in the literature, drawn from a
variety of conditions, which might be adapted or used
for people with dementia. We will develop a strategy for
promoting and supporting uptake, adherence and per-
sistence with the intervention, develop guidance on tai-
loring, need for direct supervision, and describe habit
formation and factors that predict successful adherence.
We will analyse baseline distributions, changes and as-
sociations with psychological variables hypothesised to
determine motivation and adherence, including motiv-
ation of participants to exercise (BREQ-2 [102]), and
basic psychological needs, [105], and clinician factors,
including communication style [100]), work motivation
[106], and basic psychological needs [105].
Economic analysis
Preliminary cost-effectiveness analysis will be under-
taken from a National Health Service and personal social
services (public sector multi-agency) perspective with
short-term time horizon relating to the trial follow-up
period. Cost-effectiveness analysis will be conducted in
line with NICE guidelines for technical appraisal [109]
and MRC guidelines for the evaluation of complex inter-
ventions [110]. A primary cost-effectiveness analysis will
be undertaken on cost per point improvement on the
Disability Assessment for Dementia scale. A secondary
cost-effectiveness analysis will be undertaken on the cost
per fall averted. A cost-utility analysis will be undertaken
using EQ-5D-3 L and DEMQoL as sources of utility
weights for calculating quality adjusted life years
(QALYs) [111, 112]. Data from the feasibility study will
be used to model longer-term costs and benefits to esti-
mate potential lifetime savings to the NHS and social
care of an observed improvement in ADL. Deterministic
and probabilistic sensitivity analysis will be undertaken.
Social Return on Investment (SROI) analysis will be
undertaken and a SROI ratio will be generated from the
total value of inputs and total value of outputs [113,
114]. The resulting ratio will be the amount of social
value generated for every £1 invested in the programme.
Sensitivity analysis will be conducted to vary the costs
of inputs (e.g. the cost of the staff delivering the
programme), and to vary the discount rate applied (base
case rate of 3.5%, sensitivity analysis rate of 1.5%) in
accordance with NICE guidelines [115].
Governance
An independent Programme Steering Committee and
Data Monitoring Committee have been constituted, each
with an independent chair, expert clinician, statistician
and (on the steering committee) patient and public con-
tributor. The Trial sponsor is Nottingham University
Hospitals NHS Trust.
Harwood et al. Pilot and Feasibility Studies  (2018) 4:49 Page 8 of 12
Discussion
There is a pressing need for interventions to maintain
activity and independence among people with dementia.
This is to enable people to ‘live well’, to help prevent cri-
ses, and to mitigate the increasing burden on health and
social care of dementia-related dependency. Intervening
at an early stage may enable people to establish new
health habits before the inevitable progression of demen-
tia. Fall-related injury and activity restriction are often
responsible for deterioration, or a ‘spiral of decline’. Falls
prevention for older people in general is well-
established, but this has not yet been adapted for people
with dementia.
We present the protocol of a complex study, aiming
both to establish the feasibility of conducting a large
RCT of an exercise intervention for people with early
dementia, and to optimise implementation of the inter-
vention so that the RCT will evaluate an intervention
that is practical, well-justified and suitable for wider-
scale subsequent adoption.
The development and evaluation of complex interven-
tions is a methodological challenge [73, 110]. Our stance
is that if an intervention is suitable for testing on a ran-
domised basis, then an RCT is the best method to use.
Other methodologies, such as realist evaluation, may
also contribute to understanding complex interventions.
The embedding of a process evaluation and work to
study engagement and adherence, will allow us to an-
swer questions about ‘what works, for whom, under
what circumstances and why?’ [116].
Several conditions need to be met for an RCT to be suc-
cessful. In common with all RCTs, we must establish re-
search feasibility: recruitment rates, data collection, follow-
up and the properties of outcome measures. But for com-
plex interventions, it is also necessary that the intervention
tested is deliverable and optimised. RCTs are expensive and
labour-intensive; adequate preparatory work is required to
ensure that the intervention is fit for testing, and sufficiently
well-defined to be repeatable. For applied health research
that anticipates early patient benefit, the intervention
should be suitable for widespread adoption in health care
services if the results are favourable.
Our study is designed to examine whether these
conditions are satisfied, and to enable adjustment or
adaptation in the light of experience. Our intervention is
based upon work we have conducted over several years
examining, and contributing towards, a wide body of
physiological evidence that links exercise to improved
outcomes [19, 55, 57, 92–94]. The feasibility RCT exam-
ines two variants of the exercise intervention with higher
and lower degrees of supervision, on the basis that a
lower intensity support intervention would be less
expensive to deliver, but might not ensure the long-term
adherence presumed necessary for benefits to be seen,
whilst more intensive supervision will be more expensive
but may be more effective [34–36, 48, 57]. The decision
to choose one arm or the other, or how to tailor
supervision according to individual circumstances, in a
subsequent large RCT will depend upon many factors,
critically including the degree to which long-term adher-
ence is established. This will be informed by the process
evaluation, and motivation and adherence study. Given
that both intervention arms will incur health care costs,
it is necessary to demonstrate whether there is a
reasonable likelihood of health gains before conducting
a large and expensive RCT, and any subsequent health
benefit justifies the costs of the intervention. Economic
appraisal towards the end-of-life is contentious, ideally
requiring an approach which can model costs and bene-
fits over the whole remaining lifespan, and adopting a
wider frame of reference than cost per QALY alone. For
this reason we are undertaking preliminary economic
analyses, including Markov modelling and social return
on investment analyses.
We face several methodological challenges. Research
involving people with dementia can be difficult, even
when impairments are mild. However, we have expertise
in doing such studies. We note that people with demen-
tia and their families are keen to be involved in research.
The provisions of the English Mental Capacity Act are
designed to enable inclusion, and our governance pro-
cesses ensure that studies are conducted ethically. Many
studies have demonstrated that people with dementia
can be successfully recruited to trials, and useful and
valid patient-centred outcomes can be measured. The
recording of falls and levels of activity will be challen-
ging, and will be examined in this study.
The studies described represent part of a research
programme aimed at understanding activity-limitation
among people with dementia, how to intervene to pro-
mote activity and reduce falls, and how to get such a
therapy programme to work in practice. The protocol
describes work on the final stages of developing the
intervention, preparing a definite RCT, and data for
economic modelling.
The definitive RCT is due to recruit from September
2018 and complete in 2021.
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